Misoprostol plus isosorbide mononitrate versus misoprostol alone for cervical ripening during labor induction: A systematic review and meta-analysis of randomized controlled trials
- PMID: 34583026
- DOI: 10.1016/j.jogoh.2021.102235
Misoprostol plus isosorbide mononitrate versus misoprostol alone for cervical ripening during labor induction: A systematic review and meta-analysis of randomized controlled trials
Abstract
Aim: To conduct a systematic review and meta-analysis of all randomized controlled trials (RCTs) that examined the maternal and neonatal outcomes of misoprostol+isosorbide mononitrate (ISMN) versus misoprostol alone (control) in promoting cervical ripening during labor induction.
Methods: We searched five databases from inception until 05-May-2021. We assessed risk of bias of RCTs, meta-analyzed 23 endpoints, and pooled them as mean difference or risk ratio with 95% confidence interval.
Results: Overall, five RCTs met the inclusion criteria, comprising 850 patients (426 and 424 patients were allocated to misoprostol+ISMN and misoprostol group, respectively). Overall, the RCTs had a low risk of bias. Pertaining to maternal delivery-related outcomes, there was no significant difference between both groups regarding the mean interval from drug administration to delivery, rate of vaginal delivery, rate of cesarean section delivery, and rate of need for oxytocin augmentation. Pertaining to maternal drug-related side effects, the rate of maternal headache was significantly higher in disfavor of the misoprostol+ISMN compared with misoprostol alone. However, the rates of maternal nausea, hypotension, flushing, palpitation, dizziness, postpartum hemorrhage, and uterine tachysystole did not differ between both groups. Pertaining to neonatal outcomes, there was no significant difference between both groups regarding rates of NICU admission, meconium-stained amniotic fluid, and Apgar score <7 at five minutes.
Conclusion: Compared with misoprostol alone, co-administration of misoprostol+ISMN did not correlate with superior maternal delivery-related outcomes. The rate of maternal headache was significantly higher in disfavor of the misoprostol+ISMN group. There was no significant difference between both groups regarding neonatal endpoints.
Keywords: Cervical ripening; Isosorbide mononitrate; Labor induction; Misoprostol; Nitric oxide donor; Prostaglandin E1.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Isosorbide Mononitrate Versus Dinoprostone for Cervical Ripening During Labor Induction: a Systematic Review and Meta-analysis of Randomized Controlled Trials.Reprod Sci. 2023 Feb;30(2):380-389. doi: 10.1007/s43032-022-00909-y. Epub 2022 Apr 19. Reprod Sci. 2023. PMID: 35441336
-
Intravaginal administration of isosorbide mononitrate for cervical ripening in prolonged pregnancy: a randomised clinical trial.J Obstet Gynaecol. 2020 Aug;40(6):792-796. doi: 10.1080/01443615.2019.1669546. Epub 2019 Dec 18. J Obstet Gynaecol. 2020. PMID: 31852287 Clinical Trial.
-
Maternal and neonatal outcomes with mechanical cervical dilation plus misoprostol compared to misoprostol alone for cervical ripening; a systematic review of literature and metaanalysis.Am J Obstet Gynecol MFM. 2019 May;1(2):101-111. doi: 10.1016/j.ajogmf.2019.06.003. Epub 2019 Jun 11. Am J Obstet Gynecol MFM. 2019. PMID: 33345815
-
Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.Arch Gynecol Obstet. 2011 Jul;284(1):25-30. doi: 10.1007/s00404-010-1572-4. Epub 2010 Jun 26. Arch Gynecol Obstet. 2011. PMID: 20582425 Clinical Trial.
-
Oral misoprostol and vaginal isosorbide mononitrate for labor induction: a randomized controlled trial.Obstet Gynecol. 2010 Jul;116(1):121-126. doi: 10.1097/AOG.0b013e3181e408f2. Obstet Gynecol. 2010. PMID: 20567177 Clinical Trial.
Cited by
-
Efficacy and safety of isosorbide mononitrate plus misoprostol compared to misoprostol alone in the management of the first and second trimester abortion: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2024 Jun 10;24(1):419. doi: 10.1186/s12884-024-06614-9. BMC Pregnancy Childbirth. 2024. PMID: 38858628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous